HER2 Positive Breast Carcinoma

general

A biologic subset of breast carcinoma defined by high expression of HER2, GRB7, and TRAP100, and by lack of expression of estrogen receptor (ER).

81

Centers

115

Active Trials

$458M

Cancer Funding

Specific Cancer Types(3)

Top Centers for HER2 Positive Breast Carcinoma(81)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
172.6
2
High-Volume Research Center
72.6
3
NCI Comprehensive
High-Volume Research Center
70.6
4
NCI Comprehensive
High-Volume Research Center
70.6
5
High-Volume Research Center
70.6
6
NCI Clinical
High-Volume Research Center
70.6
7
High-Volume Research Center
70.6
8
NCI Comprehensive
Active Research Program
61.7
9
NCI Comprehensive
Active Research Program
61.7
10
NCI Comprehensive
Active Research Program
61.7
11
NCI Comprehensive
Active Research Program
61.7
12
NCI Comprehensive
Active Research Program
61.7
13
NCI Comprehensive
Active Research Program
61.7
14
NCI Comprehensive
Active Research Program
61.7
15
NCI Comprehensive
Active Research Program
61.7
16
NCI Comprehensive
Active Research Program
61.7
17
NCI Comprehensive
Active Research Program
61.7
18
NCI Comprehensive
Active Research Program
61.7
19
NCI Comprehensive
Active Research Program
61.7
20
NCI Clinical
Active Research Program
61.7
21
NCI Comprehensive
Active Research Program
61.7
22
NCI Comprehensive
Active Research Program
61.7
23
NCI Comprehensive
Active Research Program
61.7
24
NCI Comprehensive
Active Research Program
61.7
25
NCI Comprehensive
Active Research Program
61.7
26
Active Research Program
61.7
27
NCI Clinical
Active Research Program
61.7
28
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
61.7
29
Active Research Program
61.7
30
NCI Comprehensive
Active Research Program
61.7
31
Active Research Program
61.7
3261.7
33
Active Research Program
61.7
34
NCI Comprehensive
Active Research Program
43.2
35
NCI Comprehensive
Active Research Program
43.2
36
NCI Comprehensive
Active Research Program
43.2
37
NCI Comprehensive
Active Research Program
43.2
38
NCI Comprehensive
Active Research Program
43.2
39
NCI Comprehensive
Active Research Program
43.2
40
NCI Comprehensive
Active Research Program
43.2
41
NCI Comprehensive
Active Research Program
43.2
42
NCI Comprehensive
Active Research Program
43.2
43
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
43.2
44
NCI Comprehensive
Active Research Program
43.2
45
NCI Comprehensive
Active Research Program
43.2
46
NCI Comprehensive
Active Research Program
43.2
47
NCI Comprehensive
Active Research Program
43.2
48
NCI Clinical
Active Research Program
43.2
49
Active Research Program
43.2
50
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
43.2
51
NCI Comprehensive
Active Research Program
43.2
52
Active Research Program
43.2
53
NCI Comprehensive
Active Research Program
43.2
54
NCI Comprehensive
Active Research Program
43.2
55
NCI Comprehensive
Active Research Program
43.2
56
NCI Comprehensive
Active Research Program
43.2
57
NCI Comprehensive
Active Research Program
43.2
58
Active Research Program
43.2
59
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
43.2
6043.2
61
Active Research Program
43.2
62
Active Research Program
43.2
63
NCI Basic_laboratory
Active Research Program
43.2
64
Active Research Program
43.2
65
Active Research Program
43.2
66
Active Research Program
43.2
67
Active Research Program
43.2
68
Active Research Program
43.2
69
Active Research Program
43.2
70
Active Research Program
43.2
71
Active Research Program
43.2
72
BC CancerVancouver, BC
Active Research Program
43.2
73
NCI Comprehensive
30.1
74
NCI Comprehensive
30.1
75
NCI Comprehensive
30.1
7630.1
7730.1
7830.1
7930.1
80
NCI Comprehensive
81

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →